ReviewFrontiers in cardiovascular medicine2023

Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention.

Peter P Toth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.